ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 157 filers reported holding ZAI LAB LTD in Q1 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,481,888 | +215.0% | 801,394 | +259.3% | 0.23% | +212.3% |
| Q2 2023 | $6,184,677 | -44.8% | 223,032 | -33.8% | 0.07% | -52.0% |
| Q1 2023 | $11,207,489 | +84.2% | 336,966 | +70.0% | 0.15% | +87.7% |
| Q4 2022 | $6,084,402 | -61.6% | 198,189 | -57.2% | 0.08% | -63.3% |
| Q3 2022 | $15,846,000 | -29.4% | 463,329 | -28.4% | 0.22% | -36.1% |
| Q2 2022 | $22,447,000 | +75.1% | 647,262 | +122.0% | 0.35% | +66.3% |
| Q1 2022 | $12,821,000 | +82.5% | 291,517 | +337.3% | 0.21% | +80.9% |
| Q3 2021 | $7,025,000 | -53.3% | 66,660 | -21.6% | 0.12% | -59.1% |
| Q2 2021 | $15,055,000 | +43.0% | 85,059 | +7.8% | 0.28% | +20.1% |
| Q1 2021 | $10,528,000 | +26.8% | 78,902 | +28.6% | 0.23% | +6.4% |
| Q4 2020 | $8,306,000 | – | 61,370 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |